BridgeBio Pharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | — | — | $92.0M |
| FY2018 | $87.6M | $464.9M | $436.1M |
| FY2019 | $155.7M | $631.7M | $363.8M |
| FY2020 | $595.7M | $703.6M | $356.1M |
| FY2021 | $1.88B | $1.01B | $393.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2017 | — | — | $92.0M |
| FY2018 | $87.6M | $464.9M | $436.1M |
| FY2019 | $155.7M | $631.7M | $363.8M |
| FY2020 | $595.7M | $703.6M | $356.1M |
| FY2021 | $1.88B | $1.01B | $393.8M |